| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |